Site identification challenges in dermatologic surgery: A physician survey

Nemeth, Shari A.; Lawrence, Naomi

doi:10.1016/j.jaad.2012.03.016

Cited by 29 publications

(7 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, a survey of 325 MMS surgeons showed 71% reporting that [5% of patients could not identify the biopsy site at time of surgery. 40 These data were corroborated by a prospective study of 333 biopsied skin cancers referred for MMS, which found that 9% of sites were unidentifiable by the patient on the day of surgery. The only significant factor distinguishing patients who were able to locate the site and those who were not was whether the area was visible to the patient.…”

Section: Wrong-site Surgery Key Pointsmentioning

confidence: 79%

Patient safety in dermatologic surgery

Hansen

Lolis

Goldberg

et al. 2015

Journal of the American Academy of Dermatology

View full text Add to dashboard Cite

Section: Wrong-site Surgery Key Pointsmentioning

confidence: 79%

Patient safety in dermatologic surgery

Hansen

Lolis

Goldberg

et al. 2015

Journal of the American Academy of Dermatology

View full text Add to dashboard Cite

“…MMS is the treatment of choice for primary and recurrent BCC located on anatomic sites requiring maximum tissue conservation for routine function. The steps in MMS include biopsy site identification, outline with marking pen, local anesthesia injection, debulking the tumor by scalpel or curette in the saucer-shaped layer, histochemical staining, and microscopic examination [23,24]. The debulking step is repeated until the tumor-free zone is achieved [25].…”

Section: Mmsmentioning

confidence: 99%

A Brief Review of Treatment Modalities for Non-Melanoma Skin Cancer

Shah

2021

Asian J Pharm Clin Res

View full text Add to dashboard Cite

NMSC (Non-melanoma skin cancer) is the most commonly occurring malignancy in Caucasians. Out of all diagnosed NMSC cases, 95% of the cases are of basal cell carcinoma and squamous cell carcinoma. The therapeutic approaches to cure or ultimately rescue the skin area affected by NMSC include surgical methods, photodynamic therapy, radiation therapy, immunotherapy, and chemotherapy. This article aims to provide a brief overview of the preliminary mechanism of action, clinical studies, advantages, and disadvantages of currently available treatment modalities.

show abstract

“…A survey of dermatologic surgeons found 71% had difficulty identifying previous biopsy sites in patients referred for Mohs Micrographic surgery, a surgery used to remove skin cancers. 1 Wrong-site surgery accounts for 13%-14% of private dermatologic malpractice claims in the United States and Great Britain. 2,3 Every biopsy should include accurate anatomic descriptors of the biopsy site in the pathology request form that accompanies the biopsy.…”

Section: Introductionmentioning

confidence: 99%

A smartphone application to improve the precision of biopsy site identification: A proof-of-concept study

DaCunha¹,

Habashi-Daniel²,

Hanson

et al. 2020

Health Informatics J

View full text Add to dashboard Cite

Dermatologists rely on skin biopsies to diagnose cutaneous tumors and rashes. Skin biopsy sites should be accurately identified with conventional anatomical site descriptors in the pathology request form. Reliance upon free-text entries to describe these biopsy sites is prone to user error and can cause medical misadventures such as wrong-site follow-up surgery. We sought to determine whether a smartphone application (RightSite) could improve the precision of biopsy site labeling. We conducted a prospective proof-of-concept study of 100 smartphone-assisted skin biopsy site identifiers with matched comparison to 100 historical controls. Student’s t-test was used to identify significant differences in the precision of anatomic descriptors before and after adoption of the application. We found a 69% improvement in precision of anatomic site labeling with the RightSite smartphone application (P < 0.0001). These data show smartphone-assisted biopsy site labeling improves the precision of anatomic site descriptors. Integrating graphical user interfaces into the electronic health records system could improve health care by standardizing anatomic site nomenclature and site-specific descriptors.

show abstract

Site identification challenges in dermatologic surgery: A physician survey

Cited by 29 publications

References 16 publications

Patient safety in dermatologic surgery

Patient safety in dermatologic surgery

A Brief Review of Treatment Modalities for Non-Melanoma Skin Cancer

A smartphone application to improve the precision of biopsy site identification: A proof-of-concept study

Contact Info

Product

Resources

About